<DOC>
	<DOCNO>NCT01116479</DOCNO>
	<brief_summary>This open two-arm interventional randomise feasibility study anaemic patient treat chemotherapy . Randomisation perform two transfusion threshold : Haemoglobin &lt; 6.0 mmol/l ( 9.9 g/dL ) versus haemoglobin &lt; 7.1 mmol/l ( 11.7 g/dL ) female 8.1 mmol/l ( 13.4 g/dL ) males.Primary end-point quality life</brief_summary>
	<brief_title>Optimal Transfusion Anaemic Cancer Patients Treated With Chemotherapy ( HaemOPtimal )</brief_title>
	<detailed_description>Title : Randomised Feasibility Study Optimal Transfusion Thresholds Anaemic Cancer Patients Treated Chemotherapy ( HaemOPtimal ) Background : Cancer patient treat chemotherapy often become anaemic , profound negative impact quality life . Blood transfusion ameliorate symptom cause anaemia . Data lag regard threshold use offering blood transfusion . Aim : The primary aim determine end-points reflect symptom cause anaemia cancer patient treat chemotherapy . The secondary aim collect data estimate sample size future definitive study compare symptom relief use different transfusion threshold . End-points : - Numeric Rating Scale measure fatigue , dizziness , palpitation , headache , dyspnea . - FACT-G , - FACT-An ( Total anemia scale ) include fatigue subscale - Patient-assessed WHO performance status Design : Open two-arm interventional randomise feasibility study Intervention : - Blood transfusion . - Randomisation two transfusion threshold : Haemoglobin &lt; 6.0 mmol/l ( 9.9 g/dL ) versus Haemoglobin &lt; 7.1 mmol/l ( 11.7 g/dL ) female 8.1 mmol/l ( 13.4 g/dL ) male . Population : Cancer patient treat chemotherapy Inclusion criterion : - Documented cancer - Planned treatment chemotherapy - Age 18 year old - Informed consent Exclusion criterion : - Heart failure ( NYHA 3 4 ) - Prior serious complication blood transfusion - Medical condition require special consideration blood transfusion - Treatment erythropoiesis-stimulating agent . Number patient : Transfusion least 30 patient intervention arm . An estimated number 90 patient randomised arm ( 180 total ) third include patient expect require transfusion .</detailed_description>
	<criteria>Documented cancer Planned treatment chemotherapy Age old 18 year Informed consent Heart failure ( NYHA 3 4 ) Prior serious complication blood transfusion Medical condition require special consideration blood transfusion Treatment erythropoiesisstimulating agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Anaemia , transfusion , cancer , chemotherapy , Quality life</keyword>
</DOC>